Parallel Advisors’s Vaxcyte PCVX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $62.1K | Buy |
1,909
+312
| +20% | +$10.1K | ﹤0.01% | 1594 |
|
|
2025
Q1 | $61K | Buy |
1,597
+1,071
| +204% | +$40.9K | ﹤0.01% | 1511 |
|
|
2024
Q4 | $43.1K | Buy |
526
+9
| +2% | +$737 | ﹤0.01% | 1709 |
|
|
2024
Q3 | $59.1K | Buy |
517
+50
| +11% | +$5.71K | ﹤0.01% | 1515 |
|
|
2024
Q2 | $35.3K | Buy |
467
+14
| +3% | +$1.06K | ﹤0.01% | 1694 |
|
|
2024
Q1 | $30.9K | Buy |
453
+42
| +10% | +$2.87K | ﹤0.01% | 1740 |
|
|
2023
Q4 | $25.8K | Buy |
411
+250
| +155% | +$15.7K | ﹤0.01% | 1785 |
|
|
2023
Q3 | $8.21K | Buy |
161
+140
| +667% | +$7.14K | ﹤0.01% | 2290 |
|
|
2023
Q2 | $1.05K | Hold |
21
| – | – | ﹤0.01% | 2916 |
|
|
2023
Q1 | $787 | Sell |
21
-6
| -22% | -$225 | ﹤0.01% | 3011 |
|
|
2022
Q4 | $1.3K | Buy |
27
+16
| +145% | +$767 | ﹤0.01% | 2832 |
|
|
2022
Q3 | $0 | Buy |
+11
| New | – | ﹤0.01% | 3399 |
|
|
2021
Q4 | – | Sell |
-28
| Closed | -$1K | – | 3242 |
|
|
2021
Q3 | $1K | Buy |
+28
| New | +$1K | ﹤0.01% | 2906 |
|